This is a multi-part message in MIME format.
------=_NextPart_000_0004_01BD64A5.5D8AC980
Content-Type: text/plain;
charset="iso-8859-1"
Content-Transfer-Encoding: quoted-printable
Frontiers in Bioscience
A Journal and Virtual library
THE BEST BIOSCIENCE HAS TO OFFER
Cited by MEDLINE, Index Medicus, BIOSIS and Chemical Abstracts
Frontiers in Bioscience (FBS) is a virtual journal and library bringing =
the most up-to-date data in life sciences and medicine to the desktop of =
every scientist. FBS offers distinct advantages over traditional print =
journals including a rapid review process, free world-wide access, =
electronic reprint, use of multimedia, and links to diverse databases =
including MEDLINE. FBS is read by over 75,000 readers internationally =
and is accessed over 200,000 times every month in the US alone. With its =
mirror sites, over 700 editors and nearly 100 managing editors, FBS is =
truly an international entity and a valuable platform for scientific =
communication. The virtual library provides numerous databases, valuable =
information as well as forms and links to thousands of Web sites of =
interest to researchers and physicians. Visit this scientific treasure =
on the Web.
Team up with distinguished scientists who contribute to FBS:
HIV-1 Nef and host cell protein kinases=20
Kalle Saksela=20
[Vol 2, pp d606-618. December 15, 1997] PubMed No: 9388166
Human immunodeficiency virus type I as a target for gene=20
therapy=20
Magn=FAs Gottfredsson and Paul R. Bohjanen=20
[Vol 2, pp d619-634, December 15, 1997] PubMed No: 9388165
Fibronectin-integrin interactions
S. Johansson, G. Svineng, K. Wennerberg, A. Armulik and L.=20
Lohikangas
[Vol 2 pp d126-146, March 1, 1997] PubMed No: 9159220
URLs:
USA: http://www.bioscience.org
Israel: http://bioinfo.weizmann.ac.il/bioscience
France: http://vega.crbm.cnrs-mop.fr/bioscience=20
Frontiers in Bioscience is a non-profit organization dedicated to =
fostering science, education and research
------=_NextPart_000_0004_01BD64A5.5D8AC980
Content-Type: text/html;
charset="iso-8859-1"
Content-Transfer-Encoding: quoted-printable
<!DOCTYPE HTML PUBLIC "-//W3C//DTD W3 HTML//EN">
<HTML>
<HEAD>
<META content=3Dtext/html;charset=3Diso-8859-1 =
http-equiv=3DContent-Type>
<META content=3D'"MSHTML 4.72.2106.6"' name=3DGENERATOR>
</HEAD>
<BODY bgColor=3D#ffffff>
<DIV>
<DIV>
<DIV><FONT face=3D"Old English Text MT,Ribbon131 Bd BT" size=3D6>
<P align=3Dcenter>Frontiers in Bioscience</P>
<P align=3Dcenter>A Journal and Virtual library</P></FONT><B><FONT =
size=3D1>
<P align=3Dcenter>THE BEST BIOSCIENCE HAS TO OFFER</P></FONT><FONT =
size=3D1>
<P align=3Dcenter>Cited by MEDLINE, Index Medicus, BIOSIS and Chemical=20
Abstracts</P></B></FONT><FONT size=3D2></FONT><FONT size=3D1>
<P>Frontiers in Bioscience (FBS) is a virtual journal and library =
bringing the=20
most up-to-date data in life sciences and medicine to the desktop of =
every=20
scientist. FBS offers distinct advantages over traditional print =
journals=20
including a rapid review process, free world-wide access, electronic =
reprint,=20
use of multimedia, and links to diverse databases including MEDLINE. FBS =
is read=20
by over 75,000 readers internationally and is accessed over 200,000 =
times every=20
month in the US alone. With its mirror sites, over 700 editors and =
nearly 100=20
managing editors, FBS is truly an international entity and a valuable =
platform=20
for scientific communication. The virtual library provides numerous =
databases,=20
valuable information as well as forms and links to thousands of Web =
sites of=20
interest to researchers and physicians. Visit this scientific treasure =
on the=20
Web.</P>
<P align=3Djustify>Team up with distinguished scientists who contribute =
to=20
FBS:</P>
<P align=3Djustify> </P>
<P align=3Djustify></P></FONT><FONT size=3D1><B>
<P align=3Djustify>HIV-1 Nef and host cell protein kinases </P></B><I>
<P align=3Djustify>Kalle Saksela </P></I>
<P align=3Djustify>[Vol 2, pp d606-618. December 15, 1997] PubMed No: =
9388166</P>
<P align=3Djustify></P><B>
<P align=3Djustify>Human immunodeficiency virus type I as a target for =
gene </P>
<P align=3Djustify>therapy </P></B><I>
<P align=3Djustify>Magnús Gottfredsson and Paul R. Bohjanen =
</P></I>
<P align=3Djustify>[Vol 2, pp d619-634, December 15, 1997] PubMed No: =
9388165</P>
<P align=3Djustify></P><B>
<P align=3Djustify>Fibronectin-integrin interactions</P></B><I>
<P align=3Djustify>S. Johansson, G. Svineng, K. Wennerberg, A. Armulik =
and L. </P>
<P align=3Djustify>Lohikangas</P></I>
<P align=3Djustify>[Vol 2 pp d126-146, March 1, 1997] PubMed No: =
9159220</P>
<P align=3Djustify></P></DIV><B>
<P> </P>
<P>URLs:</P></B>
<DIV>
<DIR>
<DIR><B>
<P>USA:</B> <I>http://www.bioscience.org</P></I><B>
<P>Israel: </B><I>http://bioinfo.weizmann.ac.il/bioscience</P></I><B>
<P>France:</B> http://<I>vega.crbm.cnrs-mop.fr/bioscience </P>
<P align=3Dcenter></P></DIR></DIR>
<P align=3Dcenter>Frontiers in Bioscience is a non-profit organization =
dedicated=20
to fostering science, education and=20
research</P></I></DIV></FONT></DIV></DIV></BODY></HTML>
------=_NextPart_000_0004_01BD64A5.5D8AC980--